1. Home
  2. XNCR vs SPTN Comparison

XNCR vs SPTN Comparison

Compare XNCR & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • SPTN
  • Stock Information
  • Founded
  • XNCR 1997
  • SPTN 1917
  • Country
  • XNCR United States
  • SPTN United States
  • Employees
  • XNCR N/A
  • SPTN N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • XNCR Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • XNCR 565.1M
  • SPTN 596.4M
  • IPO Year
  • XNCR 2013
  • SPTN N/A
  • Fundamental
  • Price
  • XNCR $8.73
  • SPTN $26.51
  • Analyst Decision
  • XNCR Buy
  • SPTN Hold
  • Analyst Count
  • XNCR 7
  • SPTN 1
  • Target Price
  • XNCR $27.50
  • SPTN $26.90
  • AVG Volume (30 Days)
  • XNCR 540.9K
  • SPTN 711.6K
  • Earning Date
  • XNCR 08-08-2025
  • SPTN 08-14-2025
  • Dividend Yield
  • XNCR N/A
  • SPTN 3.27%
  • EPS Growth
  • XNCR N/A
  • SPTN N/A
  • EPS
  • XNCR N/A
  • SPTN N/A
  • Revenue
  • XNCR $127,228,000.00
  • SPTN $9,652,685,000.00
  • Revenue This Year
  • XNCR N/A
  • SPTN $6.07
  • Revenue Next Year
  • XNCR $28.84
  • SPTN N/A
  • P/E Ratio
  • XNCR N/A
  • SPTN N/A
  • Revenue Growth
  • XNCR N/A
  • SPTN 0.26
  • 52 Week Low
  • XNCR $7.16
  • SPTN $17.30
  • 52 Week High
  • XNCR $27.24
  • SPTN $26.69
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 47.62
  • SPTN 73.62
  • Support Level
  • XNCR $9.00
  • SPTN $26.37
  • Resistance Level
  • XNCR $9.45
  • SPTN $26.65
  • Average True Range (ATR)
  • XNCR 0.45
  • SPTN 0.09
  • MACD
  • XNCR -0.01
  • SPTN -0.27
  • Stochastic Oscillator
  • XNCR 21.76
  • SPTN 5.26

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: